Filing Details
JOHNSON & JOHNSON (NYSE:JNJ) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event.
8k filedNYSE:JNJ
JOHNSON & JOHNSON (JNJ) Reports Material Event to SEC
Filing Details JOHNSON & JOHNSON (NYSE:JNJ) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event. Market Context JOHNSON &…
Market Context
JOHNSON & JOHNSON's stock currently trades at $254.93 with a market capitalization of $505.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for JOHNSON & JOHNSON's stock.
All SEC filings for JOHNSON & JOHNSON are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View JNJ Stock Page
Frequently Asked Questions
Where can I read JNJ's SEC filings?
Browse all filings on our JNJ SEC filings page.
What types of SEC filings does JOHNSON & JOHNSON file?
Public companies like JOHNSON & JOHNSON file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
